Purdue Developing Hydrocodone Drug to Rival Zohydro - National Pain Report
This new formulation (HydroContin?) is an improvement because it is once daily, but it will be abuse deterrent, likely the same abuse deterrent as the new OxyContin, which many pain patients cannot absorb.
Be sure to read:
Drug Maker Blames ‘Misinformation’ for Zohydro Controversy